Physician

Ahmaida Zeglam, M.D.

According to 2025 Medicare claims, Ahmaida Zeglam, M.D. (NPI: 1518386762) practices ophthalmology in the Gainesville, FL market, with the plurality of this provider's patient population coming from Alachua, FL. This provider's primary affiliated billing organization is GAINESVILLE EYE PHYSICIANS PA (NPI: 1992846471; TIN: 59-3340567) and primary practice location at 32605-4233. Zeglam is affiliated with the UF HEALTH ACO GAINESVILLE, LLC (ACO ID: A5468), participating under the MSSP model.

Zeglam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,532 traditional Medicare patients, billed 7,371 HCPCS/CPT codes, and received $569,319 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 4,741 prescription claims across 1,041 beneficiaries totaling $284,444 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 63 records totaling $1,528. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $94,356 to $569,319. Similarly, Part D prescription costs have moved sharply higher in recent years, from $469 to $284,444. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$291K$582K2019 Medicare payment: $94,356 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $263,178 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $449,266 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $538,358 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $582,039 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $569,319 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20195201,171$94,356
20201,1633,298$263,178
20212,0375,675$449,266
20222,4646,885$538,358
20232,5547,367$582,039
20242,5327,371$569,319

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$146K$292K2015 Drug cost: $469 (USD; Tot_Drug_Cst)2016 Drug cost: $1,395 (USD; Tot_Drug_Cst)2017 Drug cost: $1,400 (USD; Tot_Drug_Cst)2018 Drug cost: $2,487 (USD; Tot_Drug_Cst)2019 Drug cost: $10,079 (USD; Tot_Drug_Cst)2020 Drug cost: $22,641 (USD; Tot_Drug_Cst)2021 Drug cost: $138,609 (USD; Tot_Drug_Cst)2022 Drug cost: $262,561 (USD; Tot_Drug_Cst)2023 Drug cost: $292,409 (USD; Tot_Drug_Cst)2024 Drug cost: $284,444 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151423$469
2016N/R21$1,395
20171644$1,400
20181221$2,487
201966163$10,079
2020177494$22,641
20216351,930$138,609
20228933,667$262,561
20239684,229$292,409
20241,0414,741$284,444

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system2,1052,665$77
92012Established patient problem focused exam of visual system6801,164$57
92083Exam of visual field with extended testing641732$42
92134Imaging of retina665772$27
92133Imaging of optic nerve616648$23

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine793,810$76,104
Prednisolone AcetatePrednisolone Acetate55619,831$28,432
RhopressaNetarsudil Mesylate392,403$24,475
LatanoprostLatanoprost1,08084,101$17,873
LumiganBimatoprost221,855$15,896

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.63$1,528Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahmaida Zeglam, M.D.?

Tedicare shows public-source Medicare data for Ahmaida Zeglam, M.D. (NPI 1518386762), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmaida Zeglam, M.D. have ACO affiliation data?

Ahmaida Zeglam, M.D. is shown with ACO affiliation data for UF HEALTH ACO GAINESVILLE, LLC (MSSP, ACO ID A5468).

What billing organization is linked to Ahmaida Zeglam, M.D.?

Ahmaida Zeglam, M.D. is linked to GAINESVILLE EYE PHYSICIANS PA (billing NPI 1992846471) in the available physician profile data.

Does Ahmaida Zeglam, M.D. have Open Payments data?

Ahmaida Zeglam, M.D. has 63 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.